Deciphering spinal muscular atrophy: the need for more research

被引:4
作者
Farrar, Michelle Anne [1 ,2 ]
Kariyawasam, Didu Sanduni [1 ,2 ]
机构
[1] Sydney Childrens Hosp Network, Dept Neurol, Sydney, NSW 2031, Australia
[2] UNSW Sydney, Sch Clin Med, Discipline Paediat & Child Hlth, UNSW Med & Hlth, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1016/S1474-4422(23)00502-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:134 / 136
页数:3
相关论文
共 8 条
  • [1] A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy
    Barrett, Doreen
    Bilic, Sanela
    Chyung, Yung
    Cote, Shaun M.
    Iarrobino, Ryan
    Kacena, Katherine
    Kalra, Ashish
    Long, Kimberly
    Nomikos, George
    Place, Amy
    Still, James Gordon
    Vrishabhendra, Leela
    [J]. ADVANCES IN THERAPY, 2021, 38 (06) : 3203 - 3222
  • [2] Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?
    Blaschek, Astrid
    Koelbel, Heike
    Schwartz, Oliver
    Koehler, Cornelia
    Glaeser, Dieter
    Eggermann, Katja
    Hannibal, Iris
    Schara-Schmidt, Ulrike
    Mueller-Felber, Wolfgang
    Vill, Katharina
    [J]. JOURNAL OF NEUROMUSCULAR DISEASES, 2022, 9 (05) : 597 - 605
  • [3] Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme
    D'Silva, Arlene M.
    Kariyawasam, Didu S. T.
    Best, Stephanie
    Wiley, Veronica
    Farrar, Michelle A.
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2022, 64 (05) : 625 - 632
  • [4] Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
    De Vivo, Darryl C.
    Bertini, Enrico
    Swoboda, Kathryn J.
    Hwu, Wuh-Liang
    Crawford, Thomas O.
    Finkel, Richard S.
    Kirschner, Janbernd
    Kuntz, Nancy L.
    Parsons, Julie A.
    Ryan, Monique M.
    Butterfield, Russell J.
    Topaloglu, Haluk
    Ben-Omran, Tawfeg
    Sansone, Valeria A.
    Jong, Yuh-Jyh
    Shu, Francy
    Staropoli, John F.
    Kerr, Douglas
    Sandrock, Alfred W.
    Stebbins, Christopher
    Petrillo, Marco
    Braley, Gabriel
    Johnson, Kristina
    Foster, Richard
    Gheuens, Sarah
    Bhan, Ishir
    Reyna, Sandra P.
    Fradette, Stephanie
    Farwell, Wildon
    [J]. NEUROMUSCULAR DISORDERS, 2019, 29 (11) : 842 - 856
  • [5] Presymptomatic spinal muscular atrophy: a cautionary approach to the proposed new terminology
    Farrar, Michelle A.
    Kiernan, Matthew C.
    Kariyawasam, Didu S.
    [J]. BRAIN, 2023, 146 (09) : E65 - E66
  • [6] Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study
    Kariyawasam, Didu S.
    D'Silva, Arlene M.
    Sampaio, Hugo
    Briggs, Nancy
    Herbert, Karen
    Wiley, Veronica
    Farrar, Michelle A.
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2023, 7 (03) : 159 - 170
  • [7] Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy
    Kariyawasam, Didu S. T.
    D'Silva, Arlene
    Lin, Cindy
    Ryan, Monique M.
    Farrar, Michelle A.
    [J]. FRONTIERS IN NEUROLOGY, 2019, 10
  • [8] Yeo CJJ, 2024, LANCET NEUROL, V23, P205, DOI 10.1016/S1474-4422(23)00419-2